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Abstract
Glucose-induced oxidative stress can be found related to “glucose variability” 
and “glucose memory”. The irregular low and elevated glucose conditions cause 
damage to endothelial cell function than a steady, constant rise in level of glucose. 
Activation of PKC, NADPH oxidases, and mitochondrial oxidants are some of the 
pathways exhibited as a result of this aggravated cellular response. Regarding glu-
cose memory, long after the normalization elevated level of glucose in the endothe-
lial cells of diabetic rats and culture, a existance or ‘memory’ of induced basement 
membrane mRNA is expressed. This demonstrates that glucose causes dangerous 
long-term effects beyond the hyperglycemia period. Oxidative stress give rise to 
glucotoxicity and lipotoxicity which are phenomena’s related to diabetes. Following 
the pathogenesis of diabetes, hyperglycemia and hyperlipidemia exerts a supple-
mentary toxic effect on the beta-cells. So, hyperglycemia can be considered as a 
requirement for the destructive effects of lipotoxicity. Thus glucolipotoxicity can be 
considered as a substitute for lipotoxicity which relates the detrimental correlation 
between lipids and beta-cell function. Generally, the antioxidant pharmacotherapy 
can be coupled with drugs to boost the natural cellular defense mechanisms as the 
naturally existing antioxidant components, which neutralizes free radical damage. 
This considers antioxidant a boon tool for pharmacotherapeutic agent.
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1. Introduction
Diabetes is a metabolic disorder which is characterized based on the blood 
glucose level over a certain interval of time. It can also be termed as a condition that 
impairs the ability of the body to process blood sugar. This disorder has now been a 
common problem irrespective of age and gender [1]. As per the statistical surveys 
reported the count of people effected by diabetes is increasing over the world in a 
quite faster rate [2]. Diabetes are of two type in which type-1 is a chronic condition 
in which pancreas produces very little insulin, this may be due to loss of beta cells 
[3]. Beta cells dysfunction results from prolonged exposure of high level of glucose. 
Type-2 is a condition were that affects the way the body processes blood sugar [4]. 
Diabetes can lead to many complications that can show severe negative impact on 
different organs, mainly nerves, heart, kidney, eyes and blood vessels [5].
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Diabetes can cause oxidative stress which can be caused by imbalance between 
production and accumulation of reactive oxygen species, which can damage DNA, 
lipid, protein beside these it can triggers the activation of different cellular path-
ways. When these molecules which are having notable regulatory effects in the body 
if deregulated it can lead to several diabetic complication [6–8].
When there is higher concentration of reactive oxygen species in the body 
with a minimal amount of anti-oxidant enzymes it can cause oxidative stress [9]. 
Whenever an external stimuli enters the body it can lead to reduction of the amount 
of anti-oxidant enzymes in the body and can cause inflammation [10].
Free radicles contain unpaired electrons and therefore lack stability which in 
turn search for another electron to stabilize themselves resulting in process that 
damages DNA and other parts of human cell [11]. Antioxidants are substances that 
can prevent the cells from damages that can be caused by free radicles. The antioxi-
dants which is produced by the body is called endogenous antioxidants and those 
which is taken from outside is called exogenous [12].
There are many health benefits for anti-oxidants and this work pay attention on 
the benefits shown by antioxidants against oxidative stress, how it helps to reduce 
the formation of reactive species and thus in preventing or treating of diabetes and 
related complications that is the pharmacotherapy of antioxidants in treating diabe-
tes [13]. Pharmacotherapy can be the therapy utilizing a drug that can cause relief to 
a particular disease. This work focuses on the characteristics of antioxidants and the 
use of same in prevention of diabetes [14].
2.  Effect of BETA cell dysfunction and oxidative stress on hyperglycemia 
and lipotoxicity
Impaired glucose utilization can lead to hyperglycaemia. Beta cell dysfunction 
may be due to pancreatic diseases, drugs, surgery, tumors [15]. It may result from 
the long duration of exposure to high glucose, beta cells are meant to be sensitive 
towards reactive oxygen species because they are low at antioxidant enzymes such 
as catalase, SOD, GPx. Thus this end up in damaging mitochondria and blunt 
insulin secretion [16].
There are several studies that states the negative effect of oxidative stress on 
cell and tissues that finally leads to the damage of the same when there is an over 
production of reactive species that can lead to toxic effect and can cause cytostatic 
effects leads to membrane damage and can initiate cell death pathway [17]. If the 
pancreatic beta cells are healthy they can respond to nutrients and other insulin 
resistance via hyper secretion of insulin. This is done to maintain the energy level 
but this is a long process that requires a extended time period. The beta cell cannot 
withstand a response that can be compensatory which results in dysfunction of beta 
cell and death of beta cells [18].
There are also several studies that point out the impairment in beta cells can be 
due to the exposure of beta cell to the high glucose, which can cause glycolytic flux 
and thus producing reactive oxygen species including hydrogen peroxide, hydroxyl 
radicles and superoxide [19]. Hydrogen peroxide can be formed form superoxide 
this can be catalase and GPX. Many studies including in vitro and in vivo stated the 
over expression of superoxide production during diabetes [20].
There are many metabolic pathway which are activated during superoxide 
production which include advanced glycation and products (AGEs), polyol path-
way activation of protein kinase c (PKC) [21]. Conversion of glucose to sorbitol is 
done during hyperglycemia that can further leads to the reduction of nicotinamide 
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adenine dinucleotide phosphate (NADPH) and glycothione and this is the reason 
behind the reduction in the amount of antioxidants which in then can cause oxida-
tive which in then can cause oxidative stress [22, 23].
In case of AGEs, adduct is formed by the reaction of amino group with glucose, 
which can interfere with cell integrity, and can lead to the production of reactive 
oxygen species [24]. During hyperglycermia there will be production of advanced 
glycation end product, which enhance PKC and hexosamine pathway which can 
lead to oxidative stress. Excess reactive oxygen species can react with nitric oxide 
radicle firming peroxy nitriate anion and cause tissue damage [25]. The other way 
of beta cell dysfunction may be due to the high glucose along with the free fatty acid 
whose origin can be utra-abdoman fat stores. Although the exact cause for the beta 
cell dysfunction is not known there are many hypothesis that have stated mito-
chondrial dysfunction, endoplasmic stress, and oxidative stress as the cause for the 
improper functioning of beta cell [26].
Other studies has pointed out that the free fatty acid can cause negative effect 
on functions of mitochondria leading to oxidative phosphorylation uncoupling and 
generation of reactive oxygen species [27]. Therefore dysfunction of mitochondria 
and oxidative stress can be reason for impairment of endogenous antioxidant 
defense. To add more to this point free fatty acid can generate reactive oxygen 
species and can cause fragmentation of DNA. Recent experimental studies suggest 
that lipotoxicity induced beta cell death may be due to the formation of hydrogen 
peroxide in peroxisomes [28].
Free fatty acid can activate nucleus factor kappa-β (NFK β), which allows the 
translocation of some into nucleus and produce cellular effect. In the case it can lead 
to the production of cytokines and can produce nitric acid through inducible NO 
synthase (iNOS) expression [29]. By this way over production of NO by iNOS takes 
place which can react with suoeroxide and leads to production of toxic substance 
peroxynitrite [30]. Thus free fatty acid can up-regulate the expression of iNOS, 
therefore increasing the production of NO simultaneously reducing the output 
insulin. Therefore all these can be brought to a conclusion that reactive oxygen 
species. Reactive oxygen species can increase in oxidative stress can play critical role 
in diabetes development [31].
3. Antioxidant and their role IN diabetes
The substances that can delay or inhibit the oxidation of other molecules are 
termed as antioxidants. Recently therapy using antioxidants has gained more 
importance in the field of medicine and can be used in treatment of several 
diseases including diabetes [32]. Diabetes complications can be reduced to a 
greater extend with the help of antioxidants is studied in many experimental 
works. Antioxidants can be used as a drug substrate, combined drug in the treat-
ment focused in their antioxidant activity are also utilized in the treatment of 
diabetes [33].
The function of beta cell can be secured by antioxidants by fighting against 
oxidative stress, which tries to defend the beta cells. Thus it can diminish diabetes 
related complications and helps in recovering of insuli9n sensitivity. Dietary anti-
oxidant intake can also be considered as a tool in treatment of diabetes [34]. There 
are several antioxidants which are present naturally and whose intake can reduce 
the risk of this disease. Vitamin E, vitamin C, alpha lipoic acid, selenium fall under 
this category. The role played by these antioxidants at a prescribed quantity will aim 
at reducing the risk of diabetes [35].
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4. Vitamin E
It is a lipophilic antioxidant that are found in tocopherol and tocotrienol form. 
Vitamin E is a naturally occurring antioxidant and can help in defending the cells 
against oxidative stress [36]. Many studies focused on the ability of vitamin E in 
reducing the risk of hyperglycemia and their effect in using it as a combined drug in 
therapy for diabetes [37]. Hepatic lipid peroxide level is decreased in streptozotocin 
induced diabetes by vitamin E is shown in many experimental model studies [38].
The increase in the level of lipid peroxide can be due to the change in status 
of antioxidant level. Administration of vitamin E can be significantly decreased 
when supplemented by vitamin E. During diabetes the antioxidant enzyme such 
as SOD, CAT and GPX decrease [39]. Therefore the oral administration of vitamin 
E (440 mg/kg of body weight) once in a week for one month has shown positive 
results in increasing the activity of antioxidant enzyme and decreasing hyper oxide 
level [40].
Glucose in high concentration will get attached to hemoglobin forming glycosyl-
ated hemoglobin, which is a important marker for diabetes can be prevented using 
vitamin E it can also reduce HbA1C level by oxidative stress inhibition [41]. The 
exact way by which the glucose level is reduced using antioxidants is not so clear but 
it reduces the plasma glucose while increasing the metabolic of glucose in peripheral 
tissues. Thus antioxidants can reduce the risk of several disease including diabetes 
and cancer. The antioxidant activity of vitamin E which helps in curing hypergly-
cemia can reduce the micro-vascular and macro-vascular complications in people 
affected with diabetes [42].
5. Vitamin C
It is a powerful antioxidant scavengering free radicals in aqueous compart-
ment. In aqueous state, vitamin C is a chain breaking antioxidant. The stability of 
cell membrane can be increased by vitamin C [43]. On a statistical survey taken 
from the study done in diabetic research centre, Iran, a total of 84 patients was 
supplemented with 500 mg or 100 mg of ascorbic acid for 6 weeks among which 
the patients provided with 100 mg of vitamin C shown significant reduce in blood 
glucose and lipid level where as the ones treated with 500 mg did not show any 
significant response [44]. There studies carried out showed that when vitamin C 
was provided in a high dose it reduced the fasting glucose level, improved hBA1 and 
glycemia control [45].
The risk of type-2 diabetes is found to be reduced by continuous intake of 
vitamin C as a dietary source in a population based study. The correct or prescribed 
dose (as per weight of the body) of vitamin C and vitamin E can reduce the level 
of blood glucose [46]. However no further increase in SOD is found when treated 
with vitamin C. Some studies stated that decrease in plasma vitamin C and vitamin 
E during diabetes can be due to increased oxidative stress [47]. Vitamin C play 
major role in ameliorating insulin resistance of diabetic patients and can decrease or 
diminish the micro albuminuria, erythrocyte sorbitol level. All these are turned to 
be possible by vitamin C due to their antioxidant property [48].
6. Alpha lipoic acid
The injuries in cells which is caused by free radical triggering can be treated 
using alpha lipoic acid. It has the ability to restore other antioxidants such as 
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vitamin C, vitamin E glutathione. Thus can be very useful in the effective treatment 
of disease related to liver, cardiovascular disease and diabetes [49].
Alpha lipoic acid is known for improving glucose metabolism in diabetes 
patients. This can be achieved by activating threonine, tyrosine lipid kinase in 
target cell which is responsible for stimulating glucose uptake. The translocation of 
GLUT1 and GLUT4 to plasmid membrane of adipocyte and skeletal muscle is done 
by alpha lipoic acid is stated in many invitro studies [50]. This can help in increas-
ing the activity of protein in insulin signaling pathway intake of this antioxidant 
can reduce the glucose and cholesterol level. During diabetes it can regenerate 
other antioxidant including vitamin C, vitamin E and SOD. An increase of insulin 
stimulated glucose disposal is seen in diabetic patients when administrated with 
500 mg ALA for about 10 days but no change is seen in fasting plasma glucose 
level. Insulin resistance can be accured by intake of this antioxidant. Plasma insulin 
sensitivity can be raised by the oral supplementation of ALA. ALA has the ability 
to scavenge the reactive oxygen species which are produced during peroxidation 
of lipid thus saving the cells from damage. Continuous supplementation of ALA 
helps in reducing hyperglycemia as well as diabetic complication including diabetic 
nephropathy [51].
7. Selenium
This is an antioxidant which is commonly seen in several food it exist in both 
organic and inorganic form, in which organic form include selenocysteine and 
selenomethionine and selenite and selenate falls under inorganic form. This anti-
oxidant has major role in immune function. There are several clinical studies that 
proved the efficacy of selenium to treat several diseases and this power of selenium 
is due to its antioxidant activity [52]. Earlier selenium was considered as toxic as it 
caused poisoning in both human and animal but later studies proved that deficiency 
of the same can create numerous problems in both animal and humans. Glucose 
metabolism can be maintained using small concentration of selenium as it can 
mimic insulin action, but the exact mechanism of this mimicking is not understood, 
reports depicts that activation of protein which is responsible for insulin signaling 
cascade can be done by selenuium [53].
By activating kinases, sodium selenate and sodium selenite which are inorganic 
selenium are involved in insulin signaling cascade. Selenate can increase glucose 
uptake and are involved in insulin receptor phosporylation. Insulin like activity cab 
be shown by selenium is because of their glucose tolerance anf their ability to alter 
the gluconeogenic activity. There are studies which shows the combined treatment 
of selenium along with vitamin C, vitamin E and alpha lipoic acid which are studied 
to be useful in the management of diabetes. Therefore for the curing of diseases 
antioxidant based formation are commonly used now a days [54].
8. Resveratrol
It is known as polyphenolic phytoalexin that is developed in significant amounts 
in grapevines as a secondary metabolite in response to fungal infections and has 
been shown to lower the risk of cardiovascular disease. Resveratrol has been shown 
to have positive benefits on the onset and progression of atherosclerosis, including 
control of vasodilator and vasoconstrictor production, and inhibition of anti-
platelet aggregation and low density lipo protein [55]. In addition, previous research 
has shown that resveratrol supplementation reduces plaque development in animal 
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brains and other neurodegenerative diseases. Oral resveratrol significantly reduced 
brain plaque in the hypothalamus (−90%), striatum (−89%), and medial cortex 
(−48%) of mice [56].
Oral doses of resveratrol in humans are thought to minimize beta amyloid 
plaque, which is linked to aging changes in the brain. Researchers believe that resve-
ratrol’s ability to chelate Cu++ is one mechanism for plaque eradication. It appears 
to be a promising bioactive natural molecule with possible applications in phyto-
therapy or pharmacology, based on current knowledge [57]. Moreover, diabetic rats 
given resveratrol (5 mg kg1 b.w. d1) orally for 30 days had significantly lower blood 
glucose, blood urea, serum uric acid, serum creatinine, glycosylated hemoglobin, 
and reduced functions of pathophysiological enzymes including aspartate trans-
aminase (AST), alkaline phosphatase (ALP) and alanine transaminase (ALT). The 
antihyperglycemic properties of resveratrol are also demonstrated by improvements 
in plasma insulin and hemoglobin levels. According to recent studies, resveratrol 
can be an important therapeutic agent used to treat diabetes [58].
9. Cyanidins
They are primarily found in red-blue colored fruits, tomatoes, rice, potatoes, 
beans, and red wines, implying that we consume substantial quantities of these 
compounds on a regular basis from plant-based diets [59]. This anthocyanin was 
isolated from black rice, which contains high levels of cyanidin 3-glucoside, and its 
protective effect on insulin sensitivity was tested in cultured adypocytic cells which 
were exposed to tumor necrosis factor alpha (TNF-α) [60].
Adipocyte dysfunction is closely linked to the development of obesity and insu-
lin resistance. The control of kinase expression by adypocites cells is an essential 
target for obesity prevention and insulin sensitivity improvement [61]. The effects 
of cyanidin 3-glucoside on hydrogen peroxide or TNF-induced insulin resistance 
were found to be dose-dependent. The intracellular development of ROS and the 
activation of Jun N-terminal kinases were reduced when adipocytes cells were 
pretreated with cyanidin 3-glucoside [62].
By controlling the glucose transporter 4 (GLUT-4) and retinol binding protein 
4 systems, cyanidin 3-glucoside increases insulin sensitivity. Since retinol binding 
protein 4 expression is reduced in diabetic mice, cyanidin 3-glucoside lowers blood 
glucose levels and increases insulin sensitivity. Eventually, cyanidin 3-glucoside has 
been shown to protect rat brains fed ochratoxin A in a recent study [63].
Adipocyte glucose uptake and GLUT4 membrane translocation were increased 
by cyanidin-3-glucoside and its key intestinal metabolite protocatechuic acid, 
according to a study conducted [64]. There were also huge rise in nuclear PPAR 
activity, as well as adiponectin and GLUT4 output.It’s important to note that PPAR 
inhibition reversed the polyphenol-induced increases in adiponectin and GLUT4, 
implying that PPAR is directly involved in this phase. As a result of PPAR activa-
tion, cyanidin-3-glycoside and protocatechuic acid, its key intestinal metabolite, 
can exert insulin-like activities, indicating a causal relationship between this 
transcription factor and adiponectin and GLUT4 upregulation [65].
10. Antioxidant response against oxidative stress
Beta cell dysfunction which can be caused by oxidative stress which can lead 
to diabetic condition is mainly due to the poor or in efficient antioxidant defense 
mechanism. There should be a proper balance between oxidants and antioxidant 
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which is required for survival of cells and thus a healthy life. The degree to which 
component of cells that persist in oxidative state define the redox states, whereby 
oxidative stress can be prevented by a reducing environment. Therefore such a 
reducing environment should be maintained and this can be done by antioxidant 
enzymes such as SOD and catalase that can be useful in removing reactive oxygen 
species which gives more strength to the statement that endogenous antioxidant 
enzymes can stand against the negative role played by reactive oxygen species. Main 
antioxidant enzyme that helps in minimizing the oxidative stress are SOD, catalase 
and GPX [66].
The antioxidant enzymes including SOD and catalase can reduce the sus-
ceptibility of pancreatic islet to oxidative stress. Catalase can protect against the 
expression of pro-inflammatory cytokines. Thus can also protect the pancreatic 
islet against hydrogen peroxide and streptozotocin and cytokine toxicity [67]. It 
is also noted that difference in level of mitochondrial enzyme and increment in 
production of beta cells can alter susceptibility to dysfunction and development 
of diabetes. Antioxidant such as vitamin C, alpha-lipoic acid can act as cofactor in 
metabolic mitochondrial energy and can reduce the level of reactive oxygen species 
and reactive nitrogen species in pancreatic islet cells [68].
Alpha lipoic acid can reduce oxidizing forms of antioxidant including vitamin 
E and vitamin C and can increase the levels of GSH by increasing cysteine uptake 
resulting positive therapeutic advantage in diabetes. It can also improve glucose 
disposal that helps in reducing body weight that will be beneficial for diabetic obese 
patients. Lipoic acid can reduce ubiquinone which is an important component 
of mitochondrial respiratory complex [69]. There are also several plants derived 
flavonoids that has a broad spectrum of bioactivity. They show biochemical and 
pharmacological characteristics which matches antioxidant properties. Some of 
these include quercetin ginseng, curcumin. The above mentioned flavonoid can 
limit the production of reactive oxygen species, regulation of cell signaling which is 
then can result in reducing oxidative stress and controlling diabetes [70].
Vegetables and fruits hold a very high nutritional value and there are several 
studies that talk about the foods that are rich in antioxidants. There are evidences 
that states that antioxidant rich fruits and vegetables intake can reduce the risk of 
type-2 diabetes. As these fruits and vegetables are rich in the antioxidant content 
they can contribute to the reduction of oxidative stress. Fruits and vegetables are 
good source of alphalinolenic acid nd omega 3 poly unsaturated fatty acid [71].
These are several medicinal plants which has been used for the treatment of type 
2 diabetes for past years. There are more than 800 plants which shows antioxidant 
properties and thus have been using for the treatment of diabetes [72]. With the 
advancement in the technologies there has been a rapid increment in researching on 
anti-diabetic plants. Which came out with new herbs and their principles activity 
working in their anti-diabetic properties. There are plants by products that show 
anti-diabetic characteristics. Lignans, flavanoids, terpenoids are some among 
them [73].
11. Conclusion
Diabetes is a metabolic disorder which is caused due to impaired insulin 
secretion. When the beta cells are normal they respond to nutrients and insulin 
resistance by secretion of insulin in a higher mode which can balance the glucose 
intolerance. Type-2 diabetes is due to the deleterious effect of beta cells. There are 
many evidences which states that high level of glucose can lead to the generation of 
reactive oxygen species which can intern cause oxidative stress.
Antioxidants - Benefits, Sources, Mechanisms of Action
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Therefore beta cells become worse with respect to insulin secretion. In addition 
to that the production of reactive oxygen species can lead to the activation of several 
signaling pathway. Thus low antioxidant defense can lead to oxidative stress and 
beta cell dysfunction. Antioxidant treatment can increase the defense capacity to 
fight against oxidative stress. Hydrogen peroxide molecules play roles in insulin 
secretion.
This paper focused on antioxidant as a therapy for the treatment of diabetes. As 
there is no clear evidence on how the antioxidant work on curing the disease, but all 
the possible mechanisms are discussed here. Evidences from the experiments shows 
that oxidative stress can lead to dysfunction of beta cells. Redox status change and 
depletion in antioxidant occur during this stress and lead to reactive oxygen species 
production.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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